TrialClinical cancer research : an official journal of the American Association for Cancer Research2022

Evaluation of Sensitivity to Endocrine Therapy Index (SET2,3) for Response to Neoadjuvant Endocrine Therapy and Longer-Term Breast Cancer Patient Outcomes (Alliance Z1031).

Vera J Suman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.